Hualan Bioengineering approves new board, governance overhaul at meeting

Hualan Bioengineering Co., Ltd. (SZSE:002007) announced the resolutions passed at its first extraordinary general meeting of shareholders for 2025. Key outcomes included the election of a new board of directors, both non-independent and independent members, and the approval of revised and newly established governance policies. The meeting, held on July 8, 2025, saw participation from shareholders representing over 49% of the company's shares. Resolutions passed covered revisions to the company's articles of association, updates to independent director work rules, investment decision-making, and related-party transaction management, as well as the establishment of an external guarantee management system and a compensation structure for directors and senior management. All resolutions were approved by significant majorities, with detailed voting results provided in the announcement. Legal counsel affirmed the legitimacy and validity of the meeting's procedures and resolutions.